
See how Synexa Life Sciences (formerly Alderley Analytical) retooled bioanalysis — adding the ACQUITY™ Premier UPLC™ System, the Xevo™ TQ Absolute Mass Spectrometer, a lab information management system (LIMS), and robotics — to deliver robust, scalable assays to support complex, large cohort studies. Get Paul Holme’s 60-second take on what’s coming next (including the evolving therapeutic landscape and analytical toolset) and why sustainability matters.
“We are lucky that our technology suppliers understand the challenges and provide an array of solutions to help.” – Paul Holme, Synexa Life Sciences [formerly Alderley Analytical]
Fill out the form to access the Q&A and explore how:
ACQUITY, UPLC, and Xevo are trademarks of Waters Technologies Corporations.